MOUNTAIN VIEW, Calif.,
Nov. 28, 2016 /PRNewswire/
-- Omnicell, Inc. (NASDAQ: OMCL) a leading provider of
medication and supply management solutions and analytics software
for healthcare facilities, today announced they will host an
analyst and investor briefing at the Annual ASHP Midyear Meeting on
December 5, 2016.
ANNUAL ASHP MIDYEAR MEETING
Omnicell Speakers: Randall A.
Lipps, founder, chairman, president & CEO and
Peter Kuipers, executive vice
president & CFO
Date: Monday, December 5,
2016
Time: 8:00 a.m. – 10:00 a.m. PT
Location: Mandalay Bay Convention Center, Las Vegas, NV – Booth #420
Agenda:
8:00
a.m. – Product Demonstrations and Technology Review for
Analysts and Investors attending in person at Booth #420.
9:15
a.m. – Presentation and Q&A. For call in and replay
details please see below:
The presentation and Q&A can
be monitored by dialing 1-844-358-6756 within the U.S. or
1-216-562-0399 for all other locations. The Conference ID # is
27141322. The webcast can be accessed at:
http://ir.omnicell.com/events.cfm. A replay will be available
starting at 12:15 p.m. PT on
December 5, 2016 through 8:59 p.m. PT on December
15, 2016. Dial 1-855-859-2056 within the U.S. and
1-404-537-3406 for all other locations, Conference ID #
27141322.
For Investors interested in attending this event in person,
please email Michelle Smith at
michelle.smith@omnicell.com.
About Omnicell
Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create
safer and more efficient ways to manage medications and supplies
across all care settings. As a leader in medication and supply
dispensing automation, central pharmacy automation, IV robotics,
analytics software, and medication adherence and packaging systems,
Omnicell is focused on improving care across the entire healthcare
continuum—from the acute care hospital setting, to post-acute
skilled nursing and long-term care facilities, to the patient's
home.
Over 4,000 customers worldwide use Omnicell automation and
analytics solutions to increase operational efficiency, reduce
medication errors, deliver actionable intelligence and improve
patient safety. The recent acquisition of Aesynt adds distinct
capabilities, particularly in central pharmacy and IV robotics,
creating the broadest medication management product portfolio in
the industry.
The Omnicell SureMed solution provides innovative medication
adherence packaging to help reduce costly hospital readmissions.
These medication adherence solutions are used by over 17,000
institutional and retail pharmacies in North America and the United
Kingdom. These pharmacies are served via the Company's sales
channels and our solutions enable them to maintain high accuracy
and quality standards in medication dispensing and administration
while optimizing productivity and controlling costs.
For more information about Omnicell, Inc. please visit
www.omnicell.com.
OMCL-E
Logo -
http://photos.prnewswire.com/prnh/20120731/SF48971LOGO-a
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/omnicell-announces-analyst-and-investor-briefing-at-the-annual-ashp-midyear-meeting-300368754.html
SOURCE Omnicell, Inc.